arrow
S

Sumeet K. Asrani

Baylor University Medical Center
H指数:51
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reducing alcohol-associated liver disease burden in the general population

减少普通人群中酒精相关肝脏疾病的负担

2025-09-180
PRE
Real-world use of terlipressin in cirrhosis and acute kidney injury: frequent use beyond hepatorenal syndrome

特利加压素在肝硬化及急性肾损伤中的实际应用:超越肝肾综合征的频繁使用

2025-09-080
OAAI
Enhancement of Inpatient Mortality Prognostication with Machine Learning in a Prospective Global Cohort of Patients with Cirrhosis with External Validation

机器学习对全球前瞻性肝硬化患者队列院内死亡预后的增强及外部验证

2025-07-230
PRE
Defining Organ Failures in Patients With Cirrhosis: Consensus Statements

定义肝硬化患者的器官衰竭:共识声明

2025-06-090
PRE
The current landscape of in situ and ex situ machine perfusion utilization for liver grafts from cardiac donation after circulatory death donors in the US

美国心脏循环死亡后器官捐献者供肝在体和离体机器灌注利用的当前状况

2025-03-011
PRE
Phase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in Cirrhosis

III期验证:PAaM在肝硬化患者中肝癌风险分层的应用

2025-03-013
PRE
Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from Asia

急慢性肝衰竭(ACLF):来自亚洲的“京都共识”进展

2025-02-170
OAAI
Real-world practice patterns on the use of terlipressin in patients with cirrhosis and acute kidney injury- results from the ICA-GLOBAL AKI study
2025-02-010
PRE
Acute Kidney Injury in Patients With Cirrhosis and Chronic Kidney Disease: Results From the HRS-HARMONY Consortium

肝硬化合并慢性肾脏病患者中的急性肾损伤:HRS-HARMONY联盟的研究结果

2024-12-130
PRE